Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
- pharma
Origanum majorana whole
Concern score
Not assessed — no hazard data yet.
Why it's flagged
FDA NDC lists this ingredient in 10 active drug products and 10 total products.
Regulation
No restrictions found. Origanum majorana whole appears in these published regulatory listings.
- currently_marketed_ndc
- definition_level:complete
- definition_type:primary
- ingredient_type:ingredient substance
- marketed_drug_ingredient
- nsde_reference_present
- substance_class:structurally diverse
- substance_type:structurally diverse
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 10 active drug products and 10 total products.
- FDA NDC lists this ingredient in 10 active drug products and 10 total products.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as structurallydiverse.
- openFDA substance registry classifies this ingredient as structurallydiverse.Source →
Evidence
No graded sources yet for Origanum majorana whole. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
Where it appears
Prevalence of Origanum majorana whole in our catalog (fda_ndc).
Products
10
